Business
Median Technologies to Showcase iCRO’s Central and AI-Powered Imaging Services for Oncology Clinical Trials at ASCO 2025
SOPHIA ANTIPOLIS, France, May 27, 2025--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announced today that the Company will be participating in the 2025 American Society of Clinic
About this update from Median Technologies
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1240,"height":461,"url":"https://media.zenfs.com/en/business-wire.com/9df4912c10d266bafc37f6bdee1d635f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2qq.R4VhM327JhafmRe49w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM1NztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/9df4912c10d266bafc37f6bdee1d635f","width":960,"height":357},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/iKW3cKvoeRgx.cF8LfpmuA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04OTI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/9df4912c10d266bafc37f6bdee1d635f","width":1200,"height":446}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Median is a leading provider of imaging services to the world’s top oncology pharma companies","length":93,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"ASCO abstracts position Median as highly differentiated provider of AI-imaging services for oncology trials","length":107,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Median will host two presentation sessions to introduce its new solution for radiopharmaceutical image processing for oncology research at booth #11046","length":151,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":351,"olType":false},{"type":"text","content":"SOPHIA ANTIPOLIS, France, May 27, 2025--(BUSINESS WIRE)--Regulatory News:","length":73,"tagName":"p"},{"type":"text","content":"Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announced today that the Company will be participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place from May 30 to June 2, McCormick Place, Chicago, IL, USA.","length":567,"tagName":"p"},{"type":"text","content":"Median’s team will be hosting interested parties at booth #11046, South Building, Hall A, McCormick Place, from May 31 to June 2 (exhibit dates), from 9:00 am to 5:00 pm CT, where it will share the m...